Lixte Biotechnology Holdings, Inc. (LIXT)
NASDAQ·Healthcare·Biotechnology
$3.64
-4.21%
Mkt Cap $11.42M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 31, 2026 | — | — | — | — | -$0.33 | — | — | — |
| Q4 2025 Nov 12, 2025 | — | — | — | — | -$0.33 | — | — | — |
| Q3 2025 Aug 7, 2025 | — | — | — | — | -$0.29 | — | — | — |
| Q2 2025 May 12, 2025 | — | — | — | — | -$0.29 | — | — | — |
| Q1 2025 Mar 24, 2025 | — | — | — | — | -$0.27 | — | — | — |
| Q4 2024 Nov 12, 2024 | — | — | — | — | -$0.44 | — | — | — |
| Q3 2024 Aug 8, 2024 | — | — | — | — | -$0.45 | — | — | — |
| Q2 2024 May 9, 2024 | — | — | — | — | -$0.43 | — | — | — |
| Q1 2024 Mar 19, 2024 | — | — | — | — | -$0.41 | — | — | — |
| Q4 2023 Nov 9, 2023 | — | — | — | — | -$0.49 | — | — | — |
| Q3 2023 Aug 9, 2023 | — | — | — | — | -$1.00 | — | — | — |
| Q2 2023 May 10, 2023 | — | — | — | — | -$0.80 | — | — | — |
| Q1 2023 Mar 29, 2023 | — | — | — | — | -$1.00 | — | — | — |
| Q4 2022 Nov 8, 2022 | — | — | — | — | -$0.90 | — | — | — |
| Q3 2022 Aug 10, 2022 | — | — | — | — | -$1.00 | — | — | — |
| Q2 2022 May 11, 2022 | — | — | — | — | -$1.20 | — | — | — |
| Q1 2022 Mar 21, 2022 | — | — | — | — | -$1.50 | — | — | — |
| Q4 2021 Nov 10, 2021 | — | — | — | — | -$0.90 | — | — | — |
| Q3 2021 Aug 10, 2021 | — | — | — | — | -$1.27 | — | — | — |
| Q2 2021 May 12, 2021 | — | — | — | — | -$1.35 | — | — | — |